Human lung cancers potentially demonstrate synergistic mutations/deletions of more than one cancer-related genes, such as LKB1 deletion with KRAS mutation, in a subset of poorly differentiated adenocarcinomas [26]. The gene discussed is STK11; the disease is lung cancer.